Amplify Treat Test and AdvaGERMETF
13F holders, Q2 2024 (June 30)11holders
1new positions
1sold out
1famous investor
$18.22avg. 13F price*
At the end of Q2 2024, 11 institutions reported holding Amplify Treat Test and Adva (GERM) in their 13F filings, unchanged from Q1 2024. 1 opened new positions and 1 sold out. The largest holders were Susquehanna International Group, LLP ($850K), Citadel Advisors ($515K) and Federation des caisses Desjardins du Quebec ($27K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Amplify Treat Test and Adva
- CUSIP
- 032108581
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $19 |
| Exits | 1 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 17,497 shares bought and 806 shares sold, net +16,691 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| Susquehanna International Group, LLP | 0.00% | Add +13.0% | 46,695 | $850K |
| Citadel Advisors | 0.00% | Add +74.9% | 28,290 | $515K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 1,500 | $27K |
| UBS Group AG | 0.00% | Reduce -50.7% | 487 | $9K |
| Bank of Montreal | 0.00% | No change | 300 | $6K |
| Osaic Holdings, Inc. | 0.00% | Reduce -29.3% | 277 | $5K |
| City Holding Co. | 0.00% | Reduce -41.3% | 235 | $4K |
| Tucker Asset Management LLC | 0.00% | No change | 231 | $4K |
| IFP Advisors, Inc | 0.00% | No change | 200 | $4K |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 160 | $3K |
| Planning Capital Management Corp | 0.00% | New | 1 | $19 |
"% of holder's portfolio" is GERM's weight in each manager's 13F, not the share of Amplify Treat Test and Adva the manager owns.